Homer Fogle

Homer Fogle

Auto-generated profile, based on publicly available information

Homer Fogle

Division of Clinical and Translational Cancer Research, Comprehensive Cancer Center of the University of Puerto Rico, San Juan, Puerto Rico

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2023 in npj Microgravity
Verified
Journal Article
Open access
PDF file
RBRichard Barker
Richard Barker
CKColin P. S. Kruse
Colin P. S. Kruse
CJChristina Johnson
Christina Johnson
ASAmanda Saravia-Butler
Amanda Saravia-Butler
HFHomer Fogle
Homer Fogle
SGSimon Gilroy
Simon Gilroy
Spaceflight presents a multifaceted environment for plants, combining the effects on growth of many stressors and factors including altered gravity, the influence of experiment hardware, and increased radiation exposure. To help understand the plant response to this complex suite of factors this study compared transcriptomic analysis of 15Arabidopsis thalianaspaceflight experiments deposited in the National Aeronautics and Space Administration’s GeneLab data repository. These data were reanalyzed for genes showing significant differential expression in spaceflight versus ground controls using a single common computational pipeline for either the microarray or the RNA-seq datasets. Such a standardized approach to analysis should greatly increase the robustness of comparisons made between datasets. This analysis was coupled with extensive cross-referencing to a curated matrix of metadata associated with these experiments. Our study reveals that factors such as analysis type (i.e., microarray versus RNA-seq) or environmental and hardware conditions have important confounding effects on comparisons seeking to define plant reactions to spaceflight. The metadata matrix allows selection of studies with high similarity scores, i.e., that share multiple elements of experimental design, such as plant age or flight hardware. Comparisons between these studies then helps reduce the complexity in drawing conclusions arising from comparisons made between experiments with very different designs.

18 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SPSan-Huei Lai Polo
San-Huei Lai Polo
ASAmanda M. Saravia-Butler
Amanda M. Saravia-Butler
VBValery Boyko
Valery Boyko
MDMarie T. Dinh
Marie T. Dinh
YCYi-Chun Chen
Yi-Chun Chen
JGJonathan Galazka
Jonathan Galazka
Summary: To understand the physiological changes that occur in response to spaceflight, mice are transported to the International Space Station (ISS) and housed for variable periods of time before euthanasia on-orbit or return to Earth. Sample collection under such difficult conditions introduces confounding factors that need to be identified and addressed. We found large changes in the transcriptome of mouse tissues dissected and preserved on-orbit compared to tissues from mice euthanized on-orbit, preserved, and dissected after return to Earth. Changes due to preservation method eclipsed those between flight and ground samples making it difficult to identify spaceflight-specific changes. Follow-on experiments to interrogate the roles of euthanasia methods, tissue and carcass preservation protocols, and library preparation methods suggested that differences due to preservation protocols are exacerbated when coupled with polyA selection. This has important implications for the interpretation of existing datasets and the design of future experiments.

5 August 2026 in Molecular Cancer Research
Verified
Journal Article
Open access
FNFrances Heredia Negron
Frances Heredia Negron
NMNatalia Maldonado-Vazquez
Natalia Maldonado-Vazquez
HFHomer Fogle
Homer Fogle
KWKamila Wisniewska
Kamila Wisniewska
AWAustin A. Whitman
Austin A. Whitman
HFHector L. Franco
Hector L. Franco
Breast cancer metastasis remains the leading cause of disease-related mortality, yet the regulatory mechanisms enabling tumor cells to adapt to distant tissue environments remain poorly defined. In this study, we generated a multiomic resource integrating transcriptomic (RNA sequencing) and chromatin accessibility [Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq)] profiles from estrogen receptor–positive primary breast tumors and matched liver and lung metastases obtained from the same patients, including diagnostic and postmortem specimens. This design enabled direct intrapatient comparisons of primary and metastatic regulatory landscapes. We identified extensive reprogramming of chromatin accessibility and gene expression in metastatic lesions relative to primary tumors, indicating widespread regulatory remodeling. Peak-to-gene correlation analysis uncovered thousands of metastasis-associated enhancer–gene linkages, with metastatic samples exhibiting significantly increased enhancer connectivity. These rewired enhancer networks preferentially targeted clinically relevant genes, including receptor interacting serine/threonine kinase 4, inositol-3-phosphate synthase 1, and Ras-related protein Rab-3D, which were associated with three or more enhancers in metastases but not in primary tumors. Furthermore, ATAC-seq footprinting combined with gene expression analysis revealed distinct, tissue-specific transcription factor (TF) activity profiles in liver and lung metastases, including ESR1, that were not explained by TF expression levels alone. Together, these data provide a resource of metastasis-specific regulatory elements and their cognate TFs, revealing new regulatory vulnerabilities that may be therapeutically exploitable. Implications: These findings support a model in which breast cancer metastasis is driven by enhancer regulatory reprogramming, allowing tumor cells to adapt to a variety of microenvironments.

3 November 2026
Verified
Other
Open access
PDF file
FNFrances Heredia Negron
Frances Heredia Negron
NMNatalia Maldonado-Vazquez
Natalia Maldonado-Vazquez
HFHomer Fogle
Homer Fogle
KWKamila Wisniewska
Kamila Wisniewska
AWAustin A. Whitman
Austin A. Whitman
HFHector L. Franco
Hector L. Franco
Figure S2. Transcription factor footprinting and TFAS activity across metastatic tissues.

3 November 2026
Verified
Other
Open access
FNFrances Heredia Negron
Frances Heredia Negron
NMNatalia Maldonado-Vazquez
Natalia Maldonado-Vazquez
HFHomer Fogle
Homer Fogle
KWKamila Wisniewska
Kamila Wisniewska
AWAustin A. Whitman
Austin A. Whitman
HFHector L. Franco
Hector L. Franco
Supplementary Data File 2 from Integrative Transcriptional and Chromatin Analyses Reveal Enhancer-Mediated Regulatory Programs Driving Breast Cancer Metastasis

3 November 2026
Verified
Other
Open access
FNFrances Heredia Negron
Frances Heredia Negron
NMNatalia Maldonado-Vazquez
Natalia Maldonado-Vazquez
HFHomer Fogle
Homer Fogle
KWKamila Wisniewska
Kamila Wisniewska
AWAustin A. Whitman
Austin A. Whitman
HFHector L. Franco
Hector L. Franco
Breast cancer metastasis remains the leading cause of disease-related mortality, yet the regulatory mechanisms enabling tumor cells to adapt to distant tissue environments remain poorly defined. In this study, we generated a multiomic resource integrating transcriptomic (RNA sequencing) and chromatin accessibility [Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq)] profiles from estrogen receptor–positive primary breast tumors and matched liver and lung metastases obtained from the same patients, including diagnostic and postmortem specimens. This design enabled direct intrapatient comparisons of primary and metastatic regulatory landscapes. We identified extensive reprogramming of chromatin accessibility and gene expression in metastatic lesions relative to primary tumors, indicating widespread regulatory remodeling. Peak-to-gene correlation analysis uncovered thousands of metastasis-associated enhancer–gene linkages, with metastatic samples exhibiting significantly increased enhancer connectivity. These rewired enhancer networks preferentially targeted clinically relevant genes, including receptor interacting serine/threonine kinase 4, inositol-3-phosphate synthase 1, and Ras-related protein Rab-3D, which were associated with three or more enhancers in metastases but not in primary tumors. Furthermore, ATAC-seq footprinting combined with gene expression analysis revealed distinct, tissue-specific transcription factor (TF) activity profiles in liver and lung metastases, including ESR1, that were not explained by TF expression levels alone. Together, these data provide a resource of metastasis-specific regulatory elements and their cognate TFs, revealing new regulatory vulnerabilities that may be therapeutically exploitable. Implications:These findings support a model in which breast cancer metastasis is driven by enhancer regulatory reprogramming, allowing tumor cells to adapt to a variety of microenvironments.